FAIRCHEMOR Fairchem Organics Q2 FY26 results (Jul–Sep 2025) and concall
Fairchem Organics faced a challenging Q2 and H1 FY26, with significant declines in revenue, EBITDA, and PAT due to global trade disruptions, U.S. tariffs, and intense competition from Chinese players. Raw material costs remained firm, further compressing margins. The company is focusing on value-added products and new animal feed initiatives, with commercial quantities expected by April-June 2026, but previous guidance for FY25/26 has been withdrawn.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|
| Revenue | 114 | 121 | 131 | 112 |
| EBITDA | 8 | 4 | 5 | 4 |
| Net profit | 4 | 1 | 1 | 1 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
